Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131

Urology

Volumn 76, Issue 5, 2010, Pages 1143-1147

  Jacobs, Bruce L ^a   Smith, Ryan P ^a   Beriwal, Sushil ^a   Benoit, Ronald M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CESIUM 131;

ACUTE DISEASE; AGED; ARTICLE; BRACHYTHERAPY; FOLLOW UP; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROSTATE CANCER;

ACUTE DISEASE; AGED; BRACHYTHERAPY; CESIUM RADIOISOTOPES; HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; URINATION DISORDERS;

EID: 78149360842     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.12.084     Document Type: Article

References (19)

1. J.A. Cesaretti, N.N. Stone, and V.M. Skouteris Brachytherapy for the treatment of prostate cancer Cancer J 13 2007 302 312
2. L. Potter, C. Morgenstern, and E. Calugaru 12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer J Urol 173 2005 1562 1566
3. P.D. Grimm, J.C. Blasko, and J.E. Sylvester 10-Year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy Int J Radiat Oncol Biol Phys 51 2001 31 40
4. M.J. Zelefsky, T. Hollister, and A. Raben Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer Int J Radiat Oncol Biol Phys 47 2000 1261 1266
5. D.F. Penson, M.S. Litwin, and N.K. Aaronson Health related quality of life in men with prostate cancer J Urol 169 2003 1653 1661
6. T. Okaneya, S. Nishizawa, and T. Nakayama Permanent prostate brachytherapy for Japanese men: results from initial 100 patients with prostate cancer Int J Urol 14 2007 602 606
7. D. Ash, D. Bottomley, and B. Al-Qaisieh A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localized prostate cancer Radiother Oncol 84 2007 135 139
8. M.P. Van Gellekom, M.A. Moerland, and M. Van Vulpen Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry Int J Radiat Oncol Biol Phys 63 2005 772 780
9. S.J. Feigenberg, W.R. Lee, and M.L. Desilvio Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05 Int J Radiat Oncol Biol Phys 62 2005 956 964
10. W.R. Lee, R.P. McQuellon, and K. Harris-Henderson A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer Int J Radiat Oncol Biol Phys 46 2000 77 81
11. 131Cs product information sheet and company web site www.isoray.com/ Accessed October 12, 2009
12. R.R. Kinsey The NuDat program for nuclear data on the web National Nuclear Data Center, Brookhaven National Laboratory www.nndc.bnl.gov/nndc/nudat/ Accessed October 12, 2009
13. R. Nath, L.L. Anderson, and G. Luxton Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 Med Phys 22 1995 209 234
14. J.T. Wei, R.L. Dunn, and M.S. Litwin Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 2000 899 905
15. S.J. Frank, L.L. Pisters, and J. Davis An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer J Urol 177 2007 2151 2156
16. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
17. M.J. Barry, W.O. Williford, and Y. Chang Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is perceptible to patients? J Urol 154 1995 1770 1774
18. M.A. Sprangers, C.M. Moinpour, T.J. Moynihan Clinical Significance Consensus Meeting Group Assessing meaningful change in quality of life over time: a users' guide for clinicians Mayo Clin Proc 77 2002 561 571
19. S.J. Frank, L.L. Pisters, and J. Davis An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer J Urol 177 2007 2151 2156